healthcare

Sector Detector: Finally, market capitulation gives bulls a real test of conviction, plus perhaps a buying opportunity

The dark veil around China is creating a little too much uncertainty for investors, with the usual fear mongers piling on and sending the vast buy-the-dip crowd running for the sidelines until the smoke clears. Furthermore, Sabrient’s fundamentals-based SectorCast rankings have been flashing near-term defensive signals. The end result is a long overdue capitulation event that has left no market […]

Biotech Breakdown: Seeking Relief Today

At Close: IBB down 2.35% to 342 at May bottom, XBI up 0.64% to 218
—-
Two Hours to Go 2:15p EDT, NASDAQ Down 1.79% at 4792, IBB at $349
Biotech Breakdown: Relief Today Or Another Head Fake?
Biotech stocks are trying to hold the May lows with the IBB at $342 but now at $349. There is bit of buying today and most biotechnology […]

2015 2nd Quarter Market Commentary

2015 2nd Quarter Market CommentaryJuly 22, 2015 | Documents and Literature,Insight,News & Press | Editor | 0 CommentOverviewThe fireworks came out just in time for the Fourth of July.  The second quarter was relatively sleepy until the end of June when the Greek debt crisis made headlines again.  Greece rejected a cash-for-reform proposal by the EU and missed an IMF […]

Here’s the Only Kind of Stock You Should Own Right Now…

Would you rather be a have…or a have-not?If you want to be a “have” in this market, you’d better read on because the difference between the haves and the have-nots is growing.And today I’m going to show you exactly how you can profit from inequality in the stock market. You’ll even get a shot at picking up a rock-solid stock […]

Biotech Stocks Lose Momentum with Greece Crisis; Blockbuster Immunotherapy Deal

Biotech Stocks in Broad Sell-Off
The biotech sector is usually immune to macro events but today the crisis in Greece gave investors an excuse to take profits. Many biotech stocks and ETFs were down over 3% faring worse than the NASDAQ down 2.4%. The sector, as tracked by IBB, is still up 18.87% YTD after hitting a high of 383 on […]

Summer Markets: Where’s the Volatility?

Not just talking about stocks here. Everything that is usually moving is not and everything that usually doesn’t move has been moving.Bonds: have been volatile, but will decline through the Summer, most likely. Will be highly dependent on “big economic data” because this market is being pseudo-driven by the Fed.Oil: Has been doing nothing for the past 2 months, staying […]

BREAKING: One of the Biggest Stock Market Crash Indicators Since …

We just received one of the biggest stock market crash indicators we’ve seen since the 2008 financial crisis.A Bank of America Merrill Lynch note today shows the bank’s clients sold more than $4.1 billion in U.S. stocks last week. That’s the largest amount in any week since January 2008, according to analyst Jill Carey Hall.And as this chart shows, most […]

Higher Highs Speak To Bullish Conviction | Stock Market Blog …

Stocks Peak in 2000The chart below shows the 2000 peaking process in the NASDAQ. The index made a lower high, a lower low, and then dropped below the 50-day moving average shown in blue.Stocks Peak In 2007The chart below shows the 2007 peaking process in the NASDAQ. The index made a lower high, a lower low, and then dropped below […]

Big Pharma Revealed As Puppetmaster Behind Fascist TPP Secrecy

Submitted by Tyler Durden: It is no secret that US healthcare corporations have been among, if not the biggest beneficiaries of Obamacare: by “socializing” costs and spreading the reimbursement pool over the entire population in the form of a tax, pharmaceutical companies have been able to boost medical product and service costs to unprecedented levels with the help of complicit […]

Big Pharma Revealed As Puppetmaster Behind TPP Secrecy

It is no secret that US healthcare corporations have been among, if not the biggest beneficiaries of Obamacare: by “socializing” costs and spreading the reimbursement pool over the entire population in the form of a tax, pharmaceutical companies have been able to boost medical product and service costs to unprecedented levels with the help of complicit insurance companies who have […]